Electrical device for welding human tissue approved for surgical
use in Russia
12 July 2007
Corpus Christi, Texas, USA. Ukranian company International
Association Welding (IAW) has adapted welding technology to bond human
tissue in surgery. The device has been tested in over 7000 surgical
operations in the Ukraine and has now been approved for use in Russia,
giving the go-ahead for commercial production.
The device bonds and
reconnects living soft biological tissue through fusion without the use of
materials such as sutures, staples, sealant or glue.
Inc., (OTC Bulletin Board: CTUM) a technology management company that
invested in the technology, has announced that the Russian Federal Service
of Health Care and Social Development has approved the tissue welding
electro surgery generator and eight instruments for commercial use in its
hospitals and clinics.
CSMG owns the technology and exclusive world rights to the live tissue
bonding device through Live Tissue Connect, Inc. (LTC), a subsidiary
corporation formed for the development and exploitation of the platform
Donald S. Robbins, President and CEO of CSMG said, “This is an
achievement of monumental proportions for IAW and CSMG. We expect to
immediately begin implementing our plans with IAW to manufacture, market and
distribute the tissue welding electrosurgery device and hand instruments in
both Ukraine and Russia.
"Russia and Ukraine have a combined population of about 200 million
people with rich industrial, natural and scientific resources. A world class
team of surgeons, scientists, patent authors and engineers are working on
the technology at the E.O. Paton Institute of Electric Welding in Kiev,
"We believe sales in Russia and Ukraine could reach $7 to $10 million in
2008 and could grow at a rate of as much as 50% per year for the next
several years in these two rapidly expanding medical markets,” said Donald
S. Robbins, President and CEO."
“Russian clinical work was performed by
surgeons at Hospital #1 in Moscow and Povlov University Hospital in St.
Petersburg, Russia. We were only able to bring the live tissue welding
technology from an idea stage to its current level of a unique and
revolutionary surgical product because of the R&D funding and support
provided by our long time partner CSMG Technologies,” said Dr. Alexander T
Zeluichenko, Director of the International Association Welding, Kiev,
“Welding technologies are victoriously walking around the earth,
underwater and in space. Nowadays welding is being successfully used in
medicine for bonding damaged human tissue and restoring physiological
function of human organs,” says academician BE Paton, EO Paton Institute of
Electric Welding, President of the National Academy of Science, Kiev,
LTC expects to complete the commercial hand instruments,
electrocautery generator and other electrosurgery components for the tissue
welding system and begin product distribution with IAW in the 4th quarter of
2007 for the Russian and Ukrainian markets now that all necessary approvals
have been received in these countries.
Surgeons at 27 Ukraine hospitals
and clinics are using the tissue welding/bonding technology in clinical
trials. They have completed more than 7,000 human surgeries using more than
80 types of open and laparoscopic surgical procedures, demonstrating the
technology is universal in its ability to repair soft biological tissue.
These surgeries included lung, neuro-surgery, nasal septum, intestine,
stomach, skin, gall bladder, liver, spleen, blood vessels, nerves, alba
linea, uterus, bladder, gynecological, fallopian tube, ovary and testicles
and dura-matter. Cosmetic surgeries conducted with this technology include
breast reduction, breast implants, mastopexy and abdominoplasty. The
procedure involves little or no scarring, while restoring the normal
function of the body organ or tissue.
The technology was invented and developed at the internationally renowned
E.O. Paton Institute of Electric Welding, National Academy of Sciences of
Ukraine, Kiev, Ukraine, headed by Professor B.E. Paton. U.S., Australian,
Canadian and European Union patents have been issued, and additional U.S.
and foreign patents are pending, all owned by LTC.